BioCentury
ARTICLE | Clinical News

Haemophilus influenzae type b (Hib) conjugate vaccine: Began Phase I testing

November 1, 1999 8:00 AM UTC

North American Vaccine Inc. (NVX), Columbia, Md. Product: Haemophilus influenzae type b (Hib) conjugate vaccine Business: Infectious diseases Therapeutic category: Viral infection Target: Immune cells...